Logo image of ALKAL.PA

KALRAY SADIR (ALKAL.PA) Stock Fundamental Analysis

EPA:ALKAL - Euronext Paris - Matif - FR0010722819 - Common Stock - Currency: EUR

0.69  +0.02 (+3.6%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ALKAL. ALKAL was compared to 57 industry peers in the Semiconductors & Semiconductor Equipment industry. ALKAL may be in some trouble as it scores bad on both profitability and health. ALKAL is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ALKAL had negative earnings in the past year.
ALKAL had a negative operating cash flow in the past year.
ALKAL had negative earnings in each of the past 5 years.
In the past 5 years ALKAL always reported negative operating cash flow.
ALKAL.PA Yearly Net Income VS EBIT VS OCF VS FCFALKAL.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M -15M -20M

1.2 Ratios

With a Return On Assets value of -13.66%, ALKAL is not doing good in the industry: 94.83% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -28.17%, ALKAL is doing worse than 91.38% of the companies in the same industry.
Industry RankSector Rank
ROA -13.66%
ROE -28.17%
ROIC N/A
ROA(3y)-22.37%
ROA(5y)-22.81%
ROE(3y)-38.37%
ROE(5y)-38.15%
ROIC(3y)N/A
ROIC(5y)N/A
ALKAL.PA Yearly ROA, ROE, ROICALKAL.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 500 1K 1.5K 2K

1.3 Margins

ALKAL's Gross Margin of 114.84% is amongst the best of the industry. ALKAL outperforms 100.00% of its industry peers.
ALKAL's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ALKAL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 114.84%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-47.73%
GM growth 5Y-32.16%
ALKAL.PA Yearly Profit, Operating, Gross MarginsALKAL.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 500 -500 -1K

More info and screens

1

2. Health

2.1 Basic Checks

ALKAL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALKAL has more shares outstanding
ALKAL has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ALKAL has been reduced compared to a year ago.
ALKAL.PA Yearly Shares OutstandingALKAL.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
ALKAL.PA Yearly Total Debt VS Total AssetsALKAL.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of -0.62, we must say that ALKAL is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -0.62, ALKAL is not doing good in the industry: 91.38% of the companies in the same industry are doing better.
ALKAL has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.14, ALKAL is doing good in the industry, outperforming 67.24% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z -0.62
ROIC/WACCN/A
WACC10.01%
ALKAL.PA Yearly LT Debt VS Equity VS FCFALKAL.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M

2.3 Liquidity

A Current Ratio of 0.80 indicates that ALKAL may have some problems paying its short term obligations.
ALKAL has a worse Current ratio (0.80) than 93.10% of its industry peers.
ALKAL has a Quick Ratio of 0.80. This is a bad value and indicates that ALKAL is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.67, ALKAL is not doing good in the industry: 86.21% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.8
Quick Ratio 0.67
ALKAL.PA Yearly Current Assets VS Current LiabilitesALKAL.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

More info and screens

7

3. Growth

3.1 Past

ALKAL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.79%, which is quite impressive.
Looking at the last year, ALKAL shows a very strong growth in Revenue. The Revenue has grown by 57.36%.
ALKAL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 101.63% yearly.
EPS 1Y (TTM)28.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-72.42%
Revenue 1Y (TTM)57.36%
Revenue growth 3Y192.42%
Revenue growth 5Y101.63%
Sales Q2Q%-28.45%

3.2 Future

ALKAL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.00% yearly.
The Revenue is expected to grow by 39.67% on average over the next years. This is a very strong growth
EPS Next Y-97.1%
EPS Next 2Y-4.98%
EPS Next 3Y16%
EPS Next 5YN/A
Revenue Next Year-5.6%
Revenue Next 2Y-11.47%
Revenue Next 3Y5.2%
Revenue Next 5Y39.67%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ALKAL.PA Yearly Revenue VS EstimatesALKAL.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M 150M
ALKAL.PA Yearly EPS VS EstimatesALKAL.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 -0.5 -1 -1.5 -2 -2.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALKAL. In the last year negative earnings were reported.
Also next year ALKAL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALKAL.PA Price Earnings VS Forward Price EarningsALKAL.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALKAL is valued cheaply inside the industry as 93.10% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.47
ALKAL.PA Per share dataALKAL.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

A more expensive valuation may be justified as ALKAL's earnings are expected to grow with 16.00% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-4.98%
EPS Next 3Y16%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALKAL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KALRAY SADIR

EPA:ALKAL (3/7/2025, 7:00:00 PM)

0.69

+0.02 (+3.6%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)09-19 2024-09-19
Earnings (Next)04-22 2025-04-22/amc
Inst Owners5.43%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap6.40M
Analysts40
Price Target10.71 (1452.17%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.27%
PT rev (3m)2.27%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.13%
EPS NY rev (3m)-2.13%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2%
Revenue NY rev (3m)-2%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.25
P/FCF N/A
P/OCF N/A
P/B 0.15
P/tB N/A
EV/EBITDA 2.47
EPS(TTM)-1.37
EYN/A
EPS(NY)-1.24
Fwd EYN/A
FCF(TTM)-2.43
FCFYN/A
OCF(TTM)-0.19
OCFYN/A
SpS2.78
BVpS4.47
TBVpS-1.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.66%
ROE -28.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 114.84%
FCFM N/A
ROA(3y)-22.37%
ROA(5y)-22.81%
ROE(3y)-38.37%
ROE(5y)-38.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-47.73%
GM growth 5Y-32.16%
F-Score3
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Debt/EBITDA 1.44
Cap/Depr 102.85%
Cap/Sales 80.45%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.8
Quick Ratio 0.67
Altman-Z -0.62
F-Score3
WACC10.01%
ROIC/WACCN/A
Cap/Depr(3y)87.71%
Cap/Depr(5y)77.87%
Cap/Sales(3y)179.81%
Cap/Sales(5y)249.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-72.42%
EPS Next Y-97.1%
EPS Next 2Y-4.98%
EPS Next 3Y16%
EPS Next 5YN/A
Revenue 1Y (TTM)57.36%
Revenue growth 3Y192.42%
Revenue growth 5Y101.63%
Sales Q2Q%-28.45%
Revenue Next Year-5.6%
Revenue Next 2Y-11.47%
Revenue Next 3Y5.2%
Revenue Next 5Y39.67%
EBIT growth 1Y17.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year70.33%
EBIT Next 3Y40.67%
EBIT Next 5YN/A
FCF growth 1Y-95.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y77.08%
OCF growth 3YN/A
OCF growth 5YN/A